NCT07492680 2026-03-25
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Phase 2 Not yet recruiting
Bristol-Myers Squibb
ZSky Biotech Inc
Everfront Biotech Co., Ltd.
NeuGATE Theranostics
Philogen S.p.A.